vs
COMPASS MINERALS INTERNATIONAL INC(CMP)与Bio-Techne(TECH)财务数据对比。点击上方公司名可切换其他公司
COMPASS MINERALS INTERNATIONAL INC的季度营收约是Bio-Techne的1.3倍($396.1M vs $295.9M),Bio-Techne净利率更高(12.8% vs 4.7%,领先8.2%),COMPASS MINERALS INTERNATIONAL INC同比增速更快(28.9% vs -6.4%),过去两年COMPASS MINERALS INTERNATIONAL INC的营收复合增速更高(4.3% vs 4.2%)
指南针矿产国际是一家美国上市矿产企业,总部位于堪萨斯州欧弗兰帕克,是盐、氯化镁和硫酸钾等产品的领先生产商。公司面向北美和英国客户供应经处理与未经处理的散装道路除冰盐,同时向全球种植者提供植物营养产品,此外也生产民用除冰、水质调节产品及相关商用产品。
Bio-Techne是美国头部生命科学企业,面向科研、诊断及生物工艺市场需求,研发、生产并销售生命科学试剂、仪器及配套服务,产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景,可为相关领域从业者提供可靠的专业工具支持。
CMP vs TECH — 直观对比
营收规模更大
CMP
是对方的1.3倍
$295.9M
营收增速更快
CMP
高出35.4%
-6.4%
净利率更高
TECH
高出8.2%
4.7%
两年增速更快
CMP
近两年复合增速
4.2%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $396.1M | $295.9M |
| 净利润 | $18.6M | $38.0M |
| 毛利率 | 16.0% | 64.6% |
| 营业利润率 | 9.2% | 18.4% |
| 净利率 | 4.7% | 12.8% |
| 营收同比 | 28.9% | -6.4% |
| 净利润同比 | 178.8% | 68.3% |
| 每股收益(稀释后) | $0.43 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CMP
TECH
| Q4 25 | $396.1M | $295.9M | ||
| Q3 25 | $227.5M | — | ||
| Q2 25 | $214.6M | $317.0M | ||
| Q1 25 | $494.6M | $316.2M | ||
| Q4 24 | $307.2M | $297.0M | ||
| Q3 24 | $208.8M | $289.5M | ||
| Q2 24 | $202.9M | $306.1M | ||
| Q1 24 | $364.0M | $303.4M |
净利润
CMP
TECH
| Q4 25 | $18.6M | $38.0M | ||
| Q3 25 | $-7.2M | — | ||
| Q2 25 | $-17.0M | $-17.7M | ||
| Q1 25 | $-32.0M | $22.6M | ||
| Q4 24 | $-23.6M | $34.9M | ||
| Q3 24 | $-48.3M | $33.6M | ||
| Q2 24 | $-43.6M | $40.6M | ||
| Q1 24 | $-38.9M | $49.1M |
毛利率
CMP
TECH
| Q4 25 | 16.0% | 64.6% | ||
| Q3 25 | 16.9% | — | ||
| Q2 25 | 19.2% | 62.7% | ||
| Q1 25 | 15.5% | 67.9% | ||
| Q4 24 | 11.2% | 65.3% | ||
| Q3 24 | 9.3% | 63.2% | ||
| Q2 24 | 16.1% | 66.4% | ||
| Q1 24 | 19.7% | 67.4% |
营业利润率
CMP
TECH
| Q4 25 | 9.2% | 18.4% | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 7.4% | -7.5% | ||
| Q1 25 | -0.6% | 12.2% | ||
| Q4 24 | 0.2% | 16.0% | ||
| Q3 24 | -14.3% | 13.8% | ||
| Q2 24 | 2.9% | 15.0% | ||
| Q1 24 | -10.8% | 22.1% |
净利率
CMP
TECH
| Q4 25 | 4.7% | 12.8% | ||
| Q3 25 | -3.2% | — | ||
| Q2 25 | -7.9% | -5.6% | ||
| Q1 25 | -6.5% | 7.1% | ||
| Q4 24 | -7.7% | 11.7% | ||
| Q3 24 | -23.1% | 11.6% | ||
| Q2 24 | -21.5% | 13.3% | ||
| Q1 24 | -10.7% | 16.2% |
每股收益(稀释后)
CMP
TECH
| Q4 25 | $0.43 | $0.24 | ||
| Q3 25 | — | — | ||
| Q2 25 | $-0.41 | $-0.11 | ||
| Q1 25 | $-0.77 | $0.14 | ||
| Q4 24 | $-0.57 | $0.22 | ||
| Q3 24 | $-1.17 | $0.21 | ||
| Q2 24 | $-1.05 | $0.26 | ||
| Q1 24 | $-0.94 | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $46.7M | $172.9M |
| 总债务越低越好 | $890.0M | $260.0M |
| 股东权益账面价值 | $260.5M | $2.0B |
| 总资产 | $1.5B | $2.5B |
| 负债/权益比越低杠杆越低 | 3.42× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
CMP
TECH
| Q4 25 | $46.7M | $172.9M | ||
| Q3 25 | $59.7M | — | ||
| Q2 25 | $79.4M | $162.2M | ||
| Q1 25 | $49.5M | $140.7M | ||
| Q4 24 | $45.8M | $177.5M | ||
| Q3 24 | $20.2M | $187.5M | ||
| Q2 24 | $12.8M | $152.9M | ||
| Q1 24 | $38.3M | $145.3M |
总债务
CMP
TECH
| Q4 25 | $890.0M | $260.0M | ||
| Q3 25 | $839.8M | — | ||
| Q2 25 | $833.4M | $346.0M | ||
| Q1 25 | $807.6M | $330.0M | ||
| Q4 24 | $974.4M | $300.0M | ||
| Q3 24 | $921.2M | $300.0M | ||
| Q2 24 | $875.1M | $319.0M | ||
| Q1 24 | $877.2M | $389.0M |
股东权益
CMP
TECH
| Q4 25 | $260.5M | $2.0B | ||
| Q3 25 | $234.1M | — | ||
| Q2 25 | $249.8M | $1.9B | ||
| Q1 25 | $236.5M | $2.0B | ||
| Q4 24 | $263.0M | $2.1B | ||
| Q3 24 | $316.6M | $2.1B | ||
| Q2 24 | $352.1M | $2.1B | ||
| Q1 24 | $400.4M | $2.0B |
总资产
CMP
TECH
| Q4 25 | $1.5B | $2.5B | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.5B | $2.6B | ||
| Q4 24 | $1.7B | $2.7B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.7B | $2.7B |
负债/权益比
CMP
TECH
| Q4 25 | 3.42× | 0.13× | ||
| Q3 25 | 3.59× | — | ||
| Q2 25 | 3.34× | 0.18× | ||
| Q1 25 | 3.41× | 0.16× | ||
| Q4 24 | 3.70× | 0.14× | ||
| Q3 24 | 2.91× | 0.14× | ||
| Q2 24 | 2.49× | 0.15× | ||
| Q1 24 | 2.19× | 0.19× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-37.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-59.8M | — |
| 自由现金流率自由现金流/营收 | -15.1% | — |
| 资本支出强度资本支出/营收 | 5.8% | — |
| 现金转化率经营现金流/净利润 | -1.99× | — |
| 过去12个月自由现金流最近4个季度 | $94.1M | — |
8季度趋势,按日历期对齐
经营现金流
CMP
TECH
| Q4 25 | $-37.0M | — | ||
| Q3 25 | $-6.9M | — | ||
| Q2 25 | $21.8M | $98.2M | ||
| Q1 25 | $186.9M | $41.1M | ||
| Q4 24 | $-4.1M | $84.3M | ||
| Q3 24 | $-12.7M | $63.9M | ||
| Q2 24 | $-6.8M | $75.5M | ||
| Q1 24 | $86.2M | $81.0M |
自由现金流
CMP
TECH
| Q4 25 | $-59.8M | — | ||
| Q3 25 | $-22.8M | — | ||
| Q2 25 | $3.8M | $93.3M | ||
| Q1 25 | $172.9M | $31.0M | ||
| Q4 24 | $-25.9M | $77.5M | ||
| Q3 24 | $-33.6M | $54.7M | ||
| Q2 24 | $-21.5M | $57.5M | ||
| Q1 24 | $56.2M | $64.5M |
自由现金流率
CMP
TECH
| Q4 25 | -15.1% | — | ||
| Q3 25 | -10.0% | — | ||
| Q2 25 | 1.8% | 29.4% | ||
| Q1 25 | 35.0% | 9.8% | ||
| Q4 24 | -8.4% | 26.1% | ||
| Q3 24 | -16.1% | 18.9% | ||
| Q2 24 | -10.6% | 18.8% | ||
| Q1 24 | 15.4% | 21.3% |
资本支出强度
CMP
TECH
| Q4 25 | 5.8% | — | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 8.4% | 1.5% | ||
| Q1 25 | 2.8% | 3.2% | ||
| Q4 24 | 7.1% | 2.3% | ||
| Q3 24 | 10.0% | 3.2% | ||
| Q2 24 | 7.2% | 5.9% | ||
| Q1 24 | 8.2% | 5.4% |
现金转化率
CMP
TECH
| Q4 25 | -1.99× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMP
| Highway Deicing Salt | $210.8M | 53% |
| Consumer Industrial Salt | $120.7M | 30% |
| Plant Nutrition | $60.8M | 15% |
| Transferred Over Time | $2.8M | 1% |
| Other | $1.0M | 0% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |